Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID03877653

Double-Blinded Randomized Control Trial of Knee Pain Using Sub-Threshold Peripheral Nerve Stimulation

Led by Curonix LLC · Updated on 2025-02-13

100

Participants Needed

13

Research Sites

86 weeks

Total Duration

On this page

Sponsors

C

Curonix LLC

Lead Sponsor

T

Texas Institute for Pain and spine

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating the potential benefits and risks of active sub-threshold wireless neuromodulation stimulation for treating chronic knee pain caused by osteoarthritis. This trial aims to compare active stimulation versus no stimulation (sham) in reducing pain, with the primary goal of measuring the number of participants who experience at least a 50% decrease in pain on a visual analog scale after one month. Participants first undergo a diagnostic injection to confirm temporary pain relief before receiving a 7-day trial implant of the stimulation device near the target nerve. Those reporting more than 50% pain relief during this test proceed to receive a permanent implant under sedation. After a healing period of 10 days, participants are randomized to receive either active sub-threshold stimulation or sham stimulation for 30 days while both participants and staff remain unaware of group assignments. Stimulation programs include various high-frequency options. Throughout the study, participants attend in-person visits at 1 week, 1 month, 3 months, and 6 months post-randomization for physical exams, pain scales, knee function assessments, range of motion, work status, and medication use. Additional phone follow-ups are conducted at 12, 18, and 24 months to assess long-term pain relief and any adverse events. The study collects multiple outcome measures to evaluate the treatment's impact on pain and physical function over time.

CONDITIONS

Brief Title

Freedom-1 Study for Chronic Knee Pain

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Subject is over 18 years of age
  • Chronic knee pain from osteoarthritis lasting at least three months with a modified Mankoski Pain Scale score greater than 6/10
  • Diagnosed with Kellgren-Lawrence Grade II or III knee osteoarthritis confirmed by X-ray within the last year
  • Appropriate candidate for the procedure, including post-total knee replacement patients
  • Able to understand and voluntarily consent to participate
  • Willing and able to comply with study procedures and follow-up visits
  • Documented failure of at least two less invasive treatments such as physical therapy, steroids, or NSAIDs
  • No recent invasive knee procedures within specific timeframes before consent
  • Experienced more than 75% temporary pain relief from a local anesthetic nerve injection
  • Deemed neuro-psycho-socially appropriate for implantation by a clinical psychologist
Not Eligible

You will not qualify if you...

  • Significant pain in the opposite knee affecting activity level
  • Hip or foot pain greater than knee pain
  • Neurogenic or vascular claudication
  • Diagnosed with Kellgren-Lawrence Grade IV knee osteoarthritis
  • Uncontrolled major depression or psychiatric disorders
  • Uncontrolled or acute medical illnesses including coagulopathy, renal insufficiency, liver dysfunction, neurological deficits, infection, unstable angina, severe COPD
  • Chronic severe conditions interfering with pain or function assessments
  • Pregnant, planning pregnancy, or lactating women
  • Body mass index greater than 40
  • Multiple overlapping knee, foot, ankle, or radicular pain complaints
  • Anatomical restrictions making procedure inappropriate
  • Conditions compromising surgical site such as lymphedema or ulcers
  • History of adverse reaction to local anesthetics
  • Worker's compensation claimants
  • Incarcerated individuals or those with ankle position locators
  • Allergy to device materials
  • Substance abuse within the last 2 years
  • Pacemaker or implanted defibrillator
  • Participation in conflicting clinical studies
  • Any legal or medical concerns preventing enrollment
  • Presence of other active implanted medical devices at the study site

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - Single day

Participants receive a diagnostic injection near the knee nerve to assess temporary pain relief.

1 visit (in-person)

Trial Implant and Provisional Test Period

Duration - 7 days

Participants undergo a trial implant procedure with a temporary stimulator for a 7-day test period to evaluate pain relief.

1 procedure visit and daily use for 7 days

Permanent Implant

Duration - Procedure day plus 10 days

Participants with positive response receive permanent implantation of the stimulator device, followed by a 10-day healing period.

1 procedure visit and healing period with no device activation

Randomization and Blinded Treatment

Duration - Up to 30 days

Participants are randomized to receive active or sham stimulation, remaining blinded for up to 30 days while using the device.

1 visit for randomization plus device use during this period

Office Study Visits

Duration - 6 months

Participants attend follow-up visits for physical exams, pain assessment, and device adjustments with unblinding at 1 month.

Visits at 1 week, 1 month, 3 months, and 6 months (in-person)

Remote Follow-up Monitoring

Duration - Up to 24 months post-implantation

Participants complete remote follow-up phone calls to assess long-term pain relief and any adverse events.

Phone calls at 12, 18, and 24 months

Trial Site Locations

Total: 13 locations

1

Western Clinical Research

Placentia, California, United States, 92870

Actively Recruiting

2

Colorado Pain Care, LLC

Denver, Colorado, United States, 80222

Actively Recruiting

3

Holy Cross Hospital, Inc

Fort Lauderdale, Florida, United States, 33308

Actively Recruiting

4

Florida Joint Care Institute

Trinity, Florida, United States, 34655

Actively Recruiting

5

Southern Pain and research

Jasper, Georgia, United States, 30143

Actively Recruiting

6

Vista Clinical Research/Summit Spine & Joint Centers

Newnan, Georgia, United States, 30265

Actively Recruiting

7

Desert Orthopaedic Center

Las Vegas, Nevada, United States, 89149

Actively Recruiting

8

Orthopedic Associates of Southwest Ohio

Dayton, Ohio, United States, 45459

Actively Recruiting

9

Premier Pain Treatment

Loveland, Ohio, United States, 45140

Actively Recruiting

10

Kettering Health

Miamisburg, Ohio, United States, 45429

Actively Recruiting

11

Austin Orthopedic Institute

Austin, Texas, United States, 78759

Actively Recruiting

12

Performance pain and sports medicine

Houston, Texas, United States, 77027

Actively Recruiting

13

Advanced Spine and Pain Center

San Antonio, Texas, United States, 78240

Actively Recruiting

Loading map...

Research Team

N

Niek Vanquathem, BA

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

Percutaneous Transcatheter Genicular Embolization in Osteoar...

Osteoarthritic Knee Pain

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here